Choli Hartono Miriam Chung Sheng F Kuo Surya V Seshan Thangamani Muthukumar
10.1007/s40620-013-0028-x
J Nephrol
2014 Feb;27(1):103-6.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/24430762/
Boronic Acids / therapeutic use Glomerulonephritis, Membranous / drug therapy Nephrotic Syndrome / drug therapy Proteasome Inhibitors / therapeutic use Pyrazines / therapeutic use
Boronic Acids / therapeutic use Glomerulonephritis, Membranous / drug therapy Nephrotic Syndrome / drug therapy Proteasome Inhibitors / therapeutic use Pyrazines / therapeutic use Case Reports Research Support, N.I.H., Extramural Bortezomib Female Glomerulonephritis, Membranous / complications Humans Middle Aged Nephrotic Syndrome / etiology Boronic Acids Proteasome Inhibitors Pyrazines Bortezomib
PMC3966568
24430762
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy
2014